This article summarizes the highlights from the 7th China Bioanalysis Forum (CBF) Annual Conference in June 2019. The annual CBF conference provided a great platform for the Chinese bioanalytical community to discuss the current bioanalytical regulations, share challenges and experiences. With rapid growth of the pharma industry in China in the past decade and advancement in regulatory reform, the overall science and quality of regulated bioanalysis have now reached international standards. The CBF continues its efforts in promoting scientific excellence, quality and regulatory compliance in China and facilitating close collaboration with the international bioanalysis community.
Keywords: CBF; China Bioanalysis Forum; China regulatory reform; ICH M10; bioanalytical regulation.